Uroplasty to Issue First Quarter 2012 Financial Results on July 28, 2011
7:00 am ET 07/21/2011 - PR Newswire MINNEAPOLIS, July 21, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) announced today that it will release financial results for the first quarter of fiscal 2012 ended June 30, 2011, at the market close on Thursday, July 28, 2011. The Company will host a conference call to discuss these results on Thursday, July 28, 2011 at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call. Individuals wishing to participate in the conference call should dial 877-941-8609. An audio replay will be available for 30 days following the call at 800-406-7325 (domestic) and 303-590-3030 (international), with the passcode 4455479#.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in the Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent PC Neuromodulation System, which we believe is the only FDA-cleared minimally invasive, office-based neuromodulation therapy for the treatment of overactive bladder and the associated symptoms of urinary urgency, urinary frequency and urge incontinence.
We also offer Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.
in any case the investors didnt like what they saw. so i is taking a blow today which will be impactful now moving fwd. they needed to be solid in this type of industry to gt the big houses looking at them. 30% drop is no little hit.
do you really think this stock went from $1 to $8 based on macroplastique excitement? a measly $20M market.
urgent pc is the only thing that matters for this stock. that business segment has to perform very well in order to justify a 6-7x EV/sales multiple. i'm not saying it won't succeed over time, but for this quarter at least, it didn't exceed anyone's expectations.